| 000 | 01875 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515031718.0 | ||
| 264 | 0 | _c20060925 | |
| 008 | 200609s 0 0 eng d | ||
| 022 | _a1567-5769 | ||
| 024 | 7 |
_a10.1016/j.intimp.2006.02.013 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhang, Ming | |
| 245 | 0 | 0 |
_aCurcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma. _h[electronic resource] |
| 260 |
_bInternational immunopharmacology _cAug 2006 |
||
| 300 |
_a1233-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
| 650 | 0 | 4 |
_aColitis _xchemically induced |
| 650 | 0 | 4 |
_aColon _xdrug effects |
| 650 | 0 | 4 |
_aCurcumin _xpharmacology |
| 650 | 0 | 4 |
_aCyclooxygenase 2 _xgenetics |
| 650 | 0 | 4 |
_aCytokines _xgenetics |
| 650 | 0 | 4 |
_aDexamethasone _xpharmacology |
| 650 | 0 | 4 |
_aDinoprostone _xmetabolism |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 |
_aGene Expression _xdrug effects |
| 650 | 0 | 4 |
_aPPAR gamma _xgenetics |
| 650 | 0 | 4 |
_aProstaglandin D2 _xanalogs & derivatives |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 | _aSpecific Pathogen-Free Organisms |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTrinitrobenzenesulfonic Acid _xadministration & dosage |
| 650 | 0 | 4 |
_aWeight Loss _xdrug effects |
| 700 | 1 | _aDeng, Changsheng | |
| 700 | 1 | _aZheng, Jiaju | |
| 700 | 1 | _aXia, Jian | |
| 700 | 1 | _aSheng, Dan | |
| 773 | 0 |
_tInternational immunopharmacology _gvol. 6 _gno. 8 _gp. 1233-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.intimp.2006.02.013 _zAvailable from publisher's website |
| 999 |
_c16377017 _d16377017 |
||